Richard Sackler, member of family behind OxyContin, was granted patent for addiction treatment
Richard Sackler, a member of the family behind the maker of OxyContin, was granted a patent for addiction treatment.
A member of the family that owns Purdue Pharma — which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication OxyContin — has been awarded a patent for a treatment for opioid use disorder.
Dr. is listed as one of Friday by the Financial Times. Critics told the FT that they were disturbed that the patent could enable Sackler to benefit financially from the addiction crisis that his family’s company is accused of fueling.
